Sanofi has launched AccelRare, an AI tool aiding doctors in rare disease pre-diagnosis. This platform generates potential diagnoses within ...

Eli Lilly's acquisition signals a return of psychedelic drugs for mental health. These compounds offer a new approach to rewiring neural co...

Bristol Myers Squibb is buying Nvidia's latest AI computing system. This new system will support artificial intelligence in drug discovery ...

Many leaders mistake being “nice” for being effective, avoiding hard conversations and decisions in ways that ultimately undermine organiza...

Companies worldwide are experiencing a rise in AI-driven cyberattacks and ransomware incidents. Fairlife, a Coca-Cola-owned dairy company, ...

When the person who built the company steps back, emotions run high—and many organizations stumble. Here’s how to manage the transition.

Artificial intelligence is often hailed as a game changer, but too many firms discover that their bold AI pilots collapse when their operat...

European stock markets traded higher on Thursday, recovering from previous losses. Technology shares led the gains, driven by renewed inter...

The startup aims to replace costly and invasive scans with an AI-powered diagnostic platform tailored for the Indian population. Enlife on ...

Dr Reddy's chairman, Satish Reddy, has raised concerns about compromising India's competitive edge in generics for foreign investments. He ...

CDSCO still faces challenges like chronic understaffing, gaps in technical skills, weak lab infra and fragmented approvals. About a decade ...

The largest US health insurer plans to invest $3 billion in AI over 2026 and 2027. UnitedHealth executives say they’re seeing a 2-to-1 retu...

Precision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...

The Life Sciences & Pharma category at the ET Most Innovative AI Product Awards 2026. Recognises organisations leveraging AI to accelerate ...

AI is helping find participants and sites for clinical trials and drafting documents for regulators, shaving weeks ⁠off these labor-intensi...

Geographic atrophy can lead to irreversible loss of vision over time and currently affects 200 million people globally.

Mira Murati, chief technology officer at Microsoft-backed OpenAI, is joining the startup's board.